One study showed that suppression of FGFR3 increased the expression of PD-L1 level via modulating its ubiquitination in bladder cancer cells, contributing to blockade of anticancer activity of CD8+ T cells (48). Here, FGFR3 is linked to urinary bladder carcinoma.